Caina Technology Co

Caina Technology Co Equity Growth

The Year-over-Year Equity Growth of Caina Technology Co (301122.SZ) as of Nov 14, 2026 is 1.55 %. In the previous year, Year-over-Year Equity Growth was 0.24 % — a change of 552.69% (higher).

Equity Growth

1.55 %

YoY

552.69%

Last updated:

Year-over-Year Equity Growth of Caina Technology Co is 2025 1.55 % . Year-over-Year Equity Growth of Caina Technology Co was 2024 0.24 % . It decreases by 552.69% higher compared to the previous year.

The Caina Technology Co Equity Growth history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity Growth
Date
Equity Growth
Jan 1, 2018
22.60 CNY
Jan 1, 2019
56.06 CNY
Jan 1, 2020
118.68 CNY
Jan 1, 2021
34.44 CNY
Jan 1, 2022
240.38 CNY
Jan 1, 2023
4.05 CNY
Jan 1, 2024
0.24 CNY
Jan 1, 2025
1.55 CNY
The Caina Technology Co Equity Growth history
YEAREquity GrowthYoY
1.55 %+552.69%
0.24 %-94.12%
4.05 %-98.32%
240.38 %+597.95%
34.44 %-70.98%
118.68 %+111.69%
56.06 %+148.03%
22.60 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Caina Technology Co Stock analysis

What does Caina Technology Co do? Caina Technology Co., Ltd. manufactures medical consumables including puncture needles, syringes, laboratory consumables, and masks. The company's main products are reusable copper base injection needles, aluminum base injection needles, disposable aluminum-plastic inlaid injection needles, safety blood collection needles, sheathed syringes, disposable Sterile syringes, petri dishes, and reagent tubes. Caina Technology exports its products to the United States, the United Kingdom, and the European Union, serving international markets with its medical supplies. The company generates revenue through the sale of its medical consumables to global healthcare providers and distributors. Its product range targets hospitals, clinics, and laboratories requiring reliable medical equipment. Caina Technology's focus on exporting to developed markets ensures steady demand for its high-quality, compliant medical products. Caina Technology's business model relies on manufacturing and exporting medical consumables to international customers. The firm's product portfolio includes specialized items like safety blood collection needles and sterile syringes, which are essential for healthcare facilities. By targeting key regions such as the United States, United Kingdom, and European Union, the company secures consistent sales channels for its medical supplies. Caina Technology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Caina Technology Co stock

Year-over-Year Equity Growth of Caina Technology Co is 1.55 % in 2025.

On Eulerpool you can find the complete historical development of Year-over-Year Equity Growth Caina Technology Co since 2006 – with annual values, charts, and detailed analysis.

Equity growth measures the percentage change in shareholders' equity. It reflects retained earnings, share issuances, and comprehensive income effects.

To evaluate Year-over-Year Equity Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Year-over-Year Equity Growth.

Year-over-Year Equity Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Year-over-Year Equity Growth's Caina Technology Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Growth — Caina Technology Co

All Key Metrics — Caina Technology Co